One Equity Partners Completes Acquisition of PeroxyChem

One Equity Partners, the global private investment arm of J.P. Morgan Chase & Co., announced today the completion of the acquisition of PeroxyChem, formerly FMC Global Peroxygens, a business division of FMC Corporation specializing in peroxygen chemistries. The acquisition includes all sales, manufacturing, and supply chain and R&D capabilities of FMC Global Peroxygens and was valued at approximately $200 million.

PAGES 1 2 3 4 5 6 7 8 9 10